Absence of cancer-associated changes in human fibroblasts immortalized with telomerase

Nature Genetics

Volumn 21, Issue 1, 1999, Pages 115-118

  Morales, Carmela P ^a   Holt, Shawn E ^b   Ouellette, Michel ^a   Kaur, Kiran J ^a   Yan, Ying ^a   Wilson, Kathleen S ^a   White, Michael A ^a   Wright, Woodring E ^a   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TELOMERASE;

ARTICLE; CANCER; CARCINOGENESIS; CELL IMMORTALIZATION; FIBROBLAST; HUMAN; HUMAN CELL; LIFESPAN; PRIORITY JOURNAL;

CATALYTIC DOMAIN; CELL AGING; CELL DIVISION; CELL LINE; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA-BINDING PROTEINS; FIBROBLASTS; GALACTOSIDASES; HUMANS; ONCOGENE PROTEINS, VIRAL; PHOSPHORYLATION; PROTEINS; PROTO-ONCOGENE PROTEINS P21(RAS); REPRESSOR PROTEINS; RETINOBLASTOMA PROTEIN; RNA; TELOMERASE; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0032924343     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/5063     Document Type: Article

References (29)

1. Nakamura, T.M. et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 277, 955-959 (1997).
2. Meyerson, M. et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization. Cell 90, 785-795 (1997).
3. Bodnar, A.G. et al. Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352 (1998).
4. Vaziri, H. & Benchimol, S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span. Curr. Biol. 8, 279-282 (1998).
5. Shay, J.W., Wright, W.E. & Werbin, H. Defining the molecular mechanisms of human cell immortalization. Biochim. Biophys. Acta 1072, 1-7 (1991).
6. Abercrombie, M. Contact inhibition in tissue culture. In Vitro 6, 128-142 (1970).
7. Scher, C.D. & Todaro, G.J. Selective growth of human neoplastic cells in medium lacking serum growth factor. Exp. Cell Res. 68, 479-481 (1971).
8. Buchovitch, K., Duffy, L.A. & Harlow, E. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58, 1097-1105 (1989).
9. DeCaprio, J.A. et al. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58, 1085-1095 (1989).
10. Kastan, M.B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R.W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res. 51, 6304-6311 (1991).
11. Levine, A.J., Momand, J. & Finlay, C.A. The p53 tumor suppressor gene. Nature 351, 453-456 (1991).
12. DiLeonardo, A., Linke, S.P., Clarkin, K. & Wahl, G.M. DNA damage triggers a prolonged p53-dependent G1 arrest and long term induction of Cip1 in normal human fibroblasts. Genes Dev. 8, 2540-2551 (1994).
13. Cip1/Waf1 gene in normal diploid human fibroblasts. Science 277, 831-834 (1997).
14. White, A.E., Livanos, E.M. & Tlsty, T.D. Differential disruption of genomic integrity and cell cycle regulation in normal human fibroblasts by the HPV oncoproteins. Genes Dev. 8, 666-677 (1994).
15. INK4a. Cell 88, 593-602 (1997).
16. Dimri, G.P. et al. A biomarker that identifies senscent human cells in culture and in aging skin in vivo. Proc. Natl Acad. Sci. USA 92, 9363-9367 (1995).
17. Land, H., Parada, L.F. & Weinberg, R.A. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304, 596-602 (1983).
18. Newbold, R.F. & Overell, R.W. Fibroblast immortality is a prerequisite for transformation by EJ c-Ha-ras oncogene. Nature 304, 648-651 (1983).
19. Sager, R. Senescence as a mode of tumor suppression Environ. Health Perspect. 93, 59-62 (1991).
20. Nowell, P.C. & Croce, C.M. Cytogenetics of neoplasia. in Development and Recognition of the Transformed Cell (eds Greene, M.I. & Hamaoka, T.) 1-19 (Plenum, New York, 1987).
21. Honda, T. et al. Spontaneous immortalization of cultured skin fibroblasts obtained from a high-dose atomic bomb survivor. Mutat. Res. 354, 15-26 (1996).
22. Saksela, E. & Moorhead, P.S. Aneuploidy in the degenerative phase of serial cultivation of human cell strains. Proc. Natl Acad. Sci. USA 50, 390-395 (1963).
23. Benn, P.A. Specific chromosome abberations in senescent fibroblast cell lines derived from human embryos. Am. J. Hum. Genet. 28, 465-473 (1976).
24. Halbert, C.L., Demers, G.W. & Galloway, D.A. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 66, 2125-2134 (1992).
25. Holt, S.E., Gollahon, L.S., Willingham, T., Barbosa, M.S. & Shay, J.W. p53 levels in human mammary epithelial cells expressing wild-type and mutant human papilloma virus type 16 (HPV-16) E6 proteins: relationship to reactivation of telomerase and immortalization. Inter. J. Oncol. 8, 263-270 (1996).
26. Shay, J.W., Tomlinson, G., Piatyszek, M.A. & Gollahon, L.S. Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome. Mol. Cell. Biol. 15, 425-432 (1995).
27. Holt, S.E., Aisner, D.L., Shay, J.W. & Wright, W.E. Lack of cell cycle regulation of telomerase activity in human cells. Proc. Natl Acad. Sci. USA 94, 10687-10692 (1997).
28. Clark, G.J., Cox, A.D., Graham, S.M. & Der, C.J. in Methods in Enzymology (eds Balch, W.E., Der, C.J. & Hall, A.) 395-412 (Academic Press, San Diego, 1995).
29. Gustashaw K.M. in The AGT Cytogenetics Laboratory Manual (eds Barch, M.J., Knutsen, T. & Spurbeck, J.L.) 259-324 (Lippincott-Raven, Philadelphia, 1997).